Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis
暂无分享,去创建一个
Tamara Hershey | Suzanne Craft | J. Newcomer | T. Hershey | J. Olney | S. Craft | N. Farber | V. Jevtovic-Todorovic | G. Selke | A. K. Melson | Vesna Jevtovic-Todorovic | John W Newcomer | Nuri B Farber | John W Olney | Gregg Selke | Angela Kelly Melson
[1] J. Newcomer,et al. Glucose-induced increase in memory performance in patients with schizophrenia. , 1999, Schizophrenia bulletin.
[2] T. Hershey,et al. Short-term and long-term memory in early temporal lobe dysfunction. , 1998, Neuropsychology.
[3] Anil K Malhotra,et al. Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.
[4] Herbert Weingartner,et al. NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.
[5] Michael F. Green,et al. What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.
[6] Y. Sheline,et al. Memory improvement following induced hyperinsulinemia in alzheimer's disease , 1996, Neurobiology of Aging.
[7] M. Paule,et al. Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery , 1995, Pharmacology Biochemistry and Behavior.
[8] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[9] J. Kleinman,et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. , 1995, Archives of general psychiatry.
[10] Carol A. Tamminga,et al. Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.
[11] D R Medoff,et al. Ketamine activates psychosis and alters limbic blood flow in schizophrenia , 1995, Neuroreport.
[12] J. Newcomer,et al. Increased declarative memory performance during controlled hyperglycemia in patients with schizophrenia , 1995, Schizophrenia Research.
[13] T. Bliss,et al. Memories of NMDA receptors and LTP , 1995, Trends in Neurosciences.
[14] T. Yagi,et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit , 1995, Nature.
[15] T. Yagi,et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. , 1995, Nature.
[16] D. Kowalska. Effects of hippocampal lesions on spatial delayed responses in dog , 1995, Hippocampus.
[17] J. Nurnberger,et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. , 1994, Archives of general psychiatry.
[18] Brenda Milner,et al. Right-hippocampal contralateral-hand effect in the recall of spatial location in the tactual modality , 1994, Neuropsychologia.
[19] Tyrone D. Cannon,et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. , 1994, Archives of general psychiatry.
[20] E. Buffalo,et al. Acute behavioral effects of MK-801 in rhesus monkeys: Assessment using an operant test battery , 1994, Pharmacology Biochemistry and Behavior.
[21] P Alvarez,et al. The animal model of human amnesia: long-term memory impaired and short-term memory intact. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Newcomer,et al. Glucocorticoid-induced impairment in declarative memory performance in adult humans , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[24] R. Gur,et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. , 1994, Archives of general psychiatry.
[25] R Kikinis,et al. Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia. , 1993, The American journal of psychiatry.
[26] J. Newcomer,et al. Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. , 1993, Behavioral neuroscience.
[27] Ronald W. Skelton,et al. The neuropharmacological and neurochemical basis of place learning in the Morris water maze , 1993, Brain Research Reviews.
[28] T. Bliss,et al. A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.
[29] C. B. Cave,et al. Intact verbal and nonverbal short‐term memory following damage to the human hippocampus , 1992, Hippocampus.
[30] R. Morris,et al. The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] R. Depue,et al. Facilitation of Working Memory in Humans by a D2 Dopamine Receptor Agonist , 1992, Journal of Cognitive Neuroscience.
[32] V. Doyère,et al. Linear relationship between the maintenance of hippocampal long‐term potentiation and retention of an associative memory , 1992, Hippocampus.
[33] D. Ingram,et al. NMDA receptor channel antagonism by dizocilpine (MK-801) impairs performance of rats in aversively motivated complex maze tasks , 1991, Pharmacology Biochemistry and Behavior.
[34] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[35] M. Pontecorvo,et al. N-methyl-D-aspartate antagonists and working memory performance: comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine. , 1991, Behavioral neuroscience.
[36] R. Gur,et al. Neuropsychological function in schizophrenia. Selective impairment in memory and learning. , 1991, Archives of general psychiatry.
[37] P. E. Gold,et al. Effects of the novel NMDA antagonist, NPC 12626, on long-term potentiation, learning and memory , 1991, Brain Research.
[38] R. Waziri,et al. Evidence of glutamatergic deficiency in schizophrenia , 1991, Neuroscience Letters.
[39] W. Turski,et al. Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks , 1990, Neuropharmacology.
[40] H. Tilson,et al. MK-801 impedes the acquisition of a spatial memory task in rats , 1990, Pharmacology Biochemistry and Behavior.
[41] R. Morris,et al. Hippocampal synaptic plasticity and NMDA receptors: a role in information storage? , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[42] K. Jones,et al. Differential effects of σ and phencyclidine receptor ligands on learning , 1990 .
[43] W. Abraham,et al. Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats , 1990, Pharmacology Biochemistry and Behavior.
[44] Robert A. Bornstein,et al. The Wechsler Memory Scale—Revised , 1990 .
[45] V. Denoble,et al. Differential effects of sigma and phencyclidine receptor ligands on learning. , 1990, European journal of pharmacology.
[46] E. Butelman. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task , 1989, Pharmacology Biochemistry and Behavior.
[47] R. Morris. Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D- aspartate receptor antagonist AP5 , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[48] J. Olney,et al. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.
[49] D. Reich,et al. Ketamine: an update on the first twenty-five years of clinical experience , 1989, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[50] S. Deutsch,et al. A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. , 1989, Clinical neuropharmacology.
[51] P. Goldman-Rakic,et al. Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex. , 1989, Journal of neurophysiology.
[52] R. M. Nicol,et al. The performance of amnesic subjects on tests of experimental amnesia in animals: delayed matching-to-sample and concurrent learning , 1988, Neuropsychologia.
[53] J. Gruzelier,et al. Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders. , 1988, Archives of general psychiatry.
[54] E. Costa,et al. Learning impairment in rats by N-methyl-D-aspartate receptor antagonists , 1988, Neuropharmacology.
[55] L. Squire,et al. Human amnesia and animal models of amnesia: performance of amnesic patients on tests designed for the monkey. , 1988, Behavioral neuroscience.
[56] C. Reynolds,et al. Wechsler memory scale-revised , 1988 .
[57] J. Olney. Excitatory Transmitters and Neuropsychiatry Disorders , 1988 .
[58] G. Handelmann,et al. Selective memory impairment by phencyclidine in rats. , 1987, European journal of pharmacology.
[59] J. Mastropaolo,et al. Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys , 1987, Pharmacology Biochemistry and Behavior.
[60] G. Lynch,et al. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.
[61] P. Cryer,et al. External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. , 1985, The Journal of laboratory and clinical medicine.
[62] L. Squire,et al. Medial temporal lesions in monkeys impair memory on a variety of tasks sensitive to human amnesia. , 1985, Behavioral neuroscience.
[63] James V. Hinrichs,et al. Ketamine: behavioral effects of subanesthetic doses. , 1984, Journal of clinical psychopharmacology.
[64] C. P. Hughes,et al. Psychometric differentiation of mild senile dementia of the Alzheimer type. , 1984, Archives of neurology.
[65] J. M. Moerschbaecher,et al. Phenycyclidine in combination with d-amphetamine: Differential effects on acquisition and performance of response chains in monkeys , 1984, Pharmacology Biochemistry and Behavior.
[66] N C Andreasen,et al. Negative symptoms in schizophrenia , 1982 .
[67] P. White,et al. Ketamine--its pharmacology and therapeutic uses. , 1982, Anesthesiology.
[68] D. Lodge,et al. Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat. , 1982, European journal of pharmacology.
[69] A. Atkinson,et al. The pharmacological basis of therapeutics. 6th ed: By Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. 1843 pp., $45.00. Macmillan Publishing Co., Inc., New York, New York, 1980 , 1981 .
[70] H. H. Kornhuber,et al. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia , 1980, Neuroscience Letters.
[71] R. Erard,et al. The PCP psychosis: prolonged intoxication or drug-precipitated functional illness? , 1980, Journal of psychedelic drugs.
[72] R. Zukin,et al. Specific [3H]phencyclidine binding in rat central nervous system. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. Lazdunski,et al. Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membranes. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[74] G. Winocur. Effects of interference on discrimination learning and recall by rats with hippocampal lesions , 1979, Physiology & Behavior.
[75] N. Butters,et al. Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. , 1978, Archives of neurology.
[76] J. Yesavage,et al. Acute phencyclidine (PCP) intoxication: psychopathology and prognosis. , 1978, The Journal of clinical psychiatry.
[77] Christie Golden,et al. Stroop Color and Word Test: Manual for Clinical and Experimental Uses. , 1978 .
[78] D L Horwitz,et al. Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.
[79] L. Chait,et al. The behavioral pharmacology of phencyclidine. , 1976, Clinical toxicology.
[80] Elbert W. Russell,et al. A multiple scoring method for the assessment of complex memory functions. , 1975 .
[81] P. Kaniaris,et al. Serum free fatty acid and blood sugar levels in children under halothane, thiopentone and ketamine anaesthesia (comparative study) , 1975, Canadian Anaesthetists' Society journal.
[82] R. Biersner,et al. Attention, Learning, and Personality During Ketamine Emergence: A Pilot Study , 1975, Anesthesia and analgesia.
[83] J. Dundee,et al. Plasma Cortisol and blood sugar following minor surgery under intravenous anaesthetics , 1974, Anaesthesia.
[84] J. Overall. The Brief Psychiatric Rating Scale in psychopharmacology research. , 1974 .
[85] R W Farmer,et al. Plasma cortisol determination: radioimmunoassay and competitive protein binding compared. , 1974, Clinical chemistry.
[86] E. Redgate,et al. Pituitary adrenal response to ketamine and the inhibition of the response by catecholaminergic blockade. , 1974, Neuroendocrinology.
[87] J. Dundee,et al. CLINICAL STUDIES OF INDUCTION AGENTS XXXVII: AMNESIC ACTION OF KETAMINE , 1971, British journal of anaesthesia.
[88] R. C. Oldfield. The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.
[89] T. Kudo,et al. Effects of Ketamine on Adrenocortical Function in Man , 1970, Anesthesia and analgesia.
[90] Murray Sidman,et al. Some additional quantitative observations of immediate memory in a patient with bilateral hippocampal lesions , 1968 .
[91] E F Domino,et al. Dissociative Anesthesia: Further Pharmacologic Studies and First Clinical Experience with the Phencyclidine Derivative Cl‐581 , 1966, Anesthesia and analgesia.
[92] G. Rosenbaum,et al. Model psychoses and schizophrenia. , 1962, The American journal of psychiatry.
[93] G. Rosenbaum,et al. Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential thinking. , 1962, Archives of general psychiatry.
[94] C. Bakker,et al. Observations on the psychotomimetic effects of Sernyl. , 1961, Comprehensive psychiatry.
[95] H. Beech,et al. The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers. , 1960, The Journal of mental science.
[96] G. Rosenbaum,et al. Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. , 1959, A.M.A. archives of general psychiatry.
[97] M. Johnstone,et al. Sernyl (CI-395) in clinical anaesthesia. , 1959, British journal of anaesthesia.
[98] G. Rosenbaum,et al. Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.
[99] D. Wechsler. A Standardized Memory Scale for Clinical Use , 1945 .
[100] L. Goodman,et al. THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .
[101] W. Couldwell. CLINICAL STUDIES , 2022 .